// App-Quantinova.ai

: Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review

Researchers

Presenter

  • Y. AlJishi

Principal Investigators

  • M. Bosaeed

  • S. Husain

  • C. Rotstein

  • A. Humar

  • D. Kumar

Medical Centers

  • Transplant Infectious Diseases, UHN, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved